Conan Wang Group tabs

Computational design of targeted cancer therapeutics guided by machine learning

Principal advisor: Dr Conan Wang c.wang@imb.uq.edu.au

Opportunities are available to develop skills in drug discovery in computational biology and molecular biology. The aim is to accurately predict and quickly design new protein drugs to accelerate translation of new medicines. Please reach out if you would like to know more about drug design or potential projects.

Efficient design of drugs using new nanoscale technologies

Principal advisor: Dr Conan Wang c.wang@imb.uq.edu.au

Powerful technologies have emerged to perform millions of experiments quickly in tiny nanolitre droplets, and have attracted wide interest from major pharmaceutical companies because of the potential to accelerate drug discovery. Honours project opportunities are available to investigate these next-generation tools for drug design and learn new skills in one or more areas of nanotechnology and molecular biology. 

Designing protein drugs for the treatment of cancer and inflammatory diseases

Principal advisor: Dr Conan Wang c.wang@imb.uq.edu.au

Cytokines are signalling proteins that play essential roles in immune responses and have garnered clinical interest in the context of cancer, autoimmunity, and infectious disease. This project aims to overcome their limitations of poor stability, activity, and specificity to develop new therapeutics. Candidates will learn new skills in drug design and characterisation using tools in molecular biology, biochemistry, and structural biology.